Gabapentin as Adjunctive Treatment for Postoperative Pain Control

• Status: Completed
• Trial end date: 2017-06-29
• Target enrollment: 0
• Participant gender: Female

Summary

The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Indiana University
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

• Pregnant women at least 18 years of age

• Singleton gestation

• Gestational age equal to or greater than 30 weeks

• Women undergoing a non-emergent (often scheduled) repeat cesarean delivery

• Spinal anesthesia utilized during cesarean

Exclusion Criteria:

• History of opiate abuse

• Women on opiates during pregnancy

• Women requiring treatment with magnesium sulfate postpartum

• Preexisting Fibromyalgia, chronic pain syndrome, or rheumatologic disorder

• General anesthesia required for cesarean

• Plans to breastfeed

• History of major depression or postpartum depression requiring medication

• Planned classical cesarean section